State of Formation: State of Delaware
Year of Formation: 2018
Residency (HQ): New Jersey (proposed)
Year of Inception: 2020 (proposed -follow us)
The full fledged operation should start off upon making manifest the
Market Participation essential as be continually listed under the Market
Participation Planning
Investment Fund: CCECT-PT
Capital Investment Fund (proposed)
Investors
Participation: Only By Offering Memorandum
Investment Fund Manager: N/A
Investment Documents Printing: Okumaye Publishing Co, Inc
Venture
Background:
Website:
https://qualprean.enhknow (under
construction)
Company Business:
Computational Biological
Engineering Science performing Predictive Analytic Computations
of the dynamics of diseases growth in human bodies and response to
various treatments.
Company Industry:
Medical Industry with special focus on
disease growth dynamics in human body.
Production Technology: Adoption Software:
BioMedic Computations Platform:
Diseases Prognostics Analytics
Enabler Technologies:
BioSynthesis
Reaction-Sequence Computations
(All technology is licensed through EnhKnow Adoption Brokerage)
Management Contact: Opubo G Benebo,
Executive Chairman,
email:
opubob@enhknow.com
|
